Hector M González1, Wassim Tarraf2, Natalia Gouskova3, Carlos J Rodríguez4, Tatjana Rundek5, Ellen Grober6, Amber Pirzada7, Patricia González8, Pamela L Lutsey9, Alvaro Camacho10, Martha L Daviglus7, Clinton Wright5, Thomas H Mosley11. 1. Department of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, East Lansing, MI, USA. 2. Institute of Gerontology and the Department of Health Care Sciences, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, USA. 3. UNC Gillings School of Public Health, University of North Carolina, Chapel Hill, NC, USA. 4. Public Heath Sciences, Wake Forest University, Winston-Salem, NC, USA. 5. Department of Neurology, Miller School of Medicine, University of Miami, Miami, FL, USA. 6. The Saul R. Korey Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA. 7. Institute for Minority Health Research, College of Medicine at Chicago, University of Illinois at Chicago, Chicago, IL, USA. 8. Institute for Behavioral and Community Health, Graduate School of Public Health, San Diego State University, San Diego, CA, USA. 9. Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA. 10. Departments of Psychiatry, Family Medicine, and Public Health, University of California at San Diego, San Diego, CA, University of California, San Diego School of Medicine, La Jolla, CA, USA. 11. Department of Medicine (Geriatrics) and Neurology, University of Mississippi Medical Center, Jackson, MS, USA.
Abstract
BACKGROUND: Hispanics/Latinos are purportedly at increased risk for neurocognitive decline and dementias. Without dementia cures, low-cost, well-tolerated public health means for mitigating neurocognitive decline are needed. OBJECTIVE: We examined associations between neurocognition and cardiovascular health (CVH) metrics (Life's Simple 7; LS7) among diverse Hispanics/Latinos. We hypothesized that higher LS7 would be associated with healthier brain function (neurocognitive performance). METHODS: We used baseline (2008-2011) Hispanic Community Health Study/Study of Latinos (HCHS/SOL; N = 9,623; ages 45-74 years) to examine neurocognition in relation to CVH LS7 scores. RESULTS: In age and sex adjusted models, a one unit LS7 score increase (range = 0-14) was associated with higher neurocognitive function on the B-SEVLT sum (0.23 [p < 0.01]; range = 3-42), B-SEVLT recall (0.12 [p < 0.01]; range = 0-15), Word Fluency (phonemic; 0.46 (p < 0.01); range = 0-49), and Digit Symbol Substitution (0.49 (p < 0.01); range = 0-83) tests, respectively. Stated differently, a change from the minimum LS7 (0) to maximum LS7 (14) score corresponded to higher scores on verbal learning (4.62) and memory (2.24), verbal fluency (7.0), and psychomotor processing speed (12). In fully adjusted models the associations were attenuated, but remained statistically significant. Incremental adjustments indicated that Latino background and, to a lesser extent, education were primary contributors to the evinced attenuations. CONCLUSIONS: We found that higher neurocognitive function was associated with better LS7 CVH metrics among middle-aged and older Hispanics/Latinos. Associations between neurocognitive function and LS7 were strongest among two at-risk groups for neurocognitive decline and dementia, women and Hispanics/Latinos with lower education. Public health efforts to reduce cardiovascular disease morbidity and mortality may have additional neurocognitive benefits among at-risk Hispanics/Latinos.
BACKGROUND: Hispanics/Latinos are purportedly at increased risk for neurocognitive decline and dementias. Without dementia cures, low-cost, well-tolerated public health means for mitigating neurocognitive decline are needed. OBJECTIVE: We examined associations between neurocognition and cardiovascular health (CVH) metrics (Life's Simple 7; LS7) among diverse Hispanics/Latinos. We hypothesized that higher LS7 would be associated with healthier brain function (neurocognitive performance). METHODS: We used baseline (2008-2011) Hispanic Community Health Study/Study of Latinos (HCHS/SOL; N = 9,623; ages 45-74 years) to examine neurocognition in relation to CVH LS7 scores. RESULTS: In age and sex adjusted models, a one unit LS7 score increase (range = 0-14) was associated with higher neurocognitive function on the B-SEVLT sum (0.23 [p < 0.01]; range = 3-42), B-SEVLT recall (0.12 [p < 0.01]; range = 0-15), Word Fluency (phonemic; 0.46 (p < 0.01); range = 0-49), and Digit Symbol Substitution (0.49 (p < 0.01); range = 0-83) tests, respectively. Stated differently, a change from the minimum LS7 (0) to maximum LS7 (14) score corresponded to higher scores on verbal learning (4.62) and memory (2.24), verbal fluency (7.0), and psychomotor processing speed (12). In fully adjusted models the associations were attenuated, but remained statistically significant. Incremental adjustments indicated that Latino background and, to a lesser extent, education were primary contributors to the evinced attenuations. CONCLUSIONS: We found that higher neurocognitive function was associated with better LS7 CVH metrics among middle-aged and older Hispanics/Latinos. Associations between neurocognitive function and LS7 were strongest among two at-risk groups for neurocognitive decline and dementia, women and Hispanics/Latinos with lower education. Public health efforts to reduce cardiovascular disease morbidity and mortality may have additional neurocognitive benefits among at-risk Hispanics/Latinos.
Authors: Donald M Lloyd-Jones; Yuling Hong; Darwin Labarthe; Dariush Mozaffarian; Lawrence J Appel; Linda Van Horn; Kurt Greenlund; Stephen Daniels; Graham Nichol; Gordon F Tomaselli; Donna K Arnett; Gregg C Fonarow; P Michael Ho; Michael S Lauer; Frederick A Masoudi; Rose Marie Robertson; Véronique Roger; Lee H Schwamm; Paul Sorlie; Clyde W Yancy; Wayne D Rosamond Journal: Circulation Date: 2010-01-20 Impact factor: 29.690
Authors: Matthew Baumgart; Heather M Snyder; Maria C Carrillo; Sam Fazio; Hye Kim; Harry Johns Journal: Alzheimers Dement Date: 2015-06-01 Impact factor: 21.566
Authors: Paul D Sorlie; Larissa M Avilés-Santa; Sylvia Wassertheil-Smoller; Robert C Kaplan; Martha L Daviglus; Aida L Giachello; Neil Schneiderman; Leopoldo Raij; Gregory Talavera; Matthew Allison; Lisa Lavange; Lloyd E Chambless; Gerardo Heiss Journal: Ann Epidemiol Date: 2010-08 Impact factor: 3.797
Authors: Jared P Reis; Catherine M Loria; Lenore J Launer; Stephen Sidney; Kiang Liu; David R Jacobs; Na Zhu; Donald M Lloyd-Jones; Ka He; Kristine Yaffe Journal: Ann Neurol Date: 2013-02-26 Impact factor: 10.422
Authors: Hector M González; Wassim Tarraf; Carlos J Rodríguez; Linda C Gallo; Ralph L Sacco; Gregory A Talavera; Gerardo Heiss; Jorge R Kizer; Rosalba Hernandez; Sonia Davis; Neil Schneiderman; Martha L Daviglus; Robert C Kaplan Journal: Am Heart J Date: 2016-02-19 Impact factor: 4.749
Authors: Christopher M Callahan; Frederick W Unverzagt; Siu L Hui; Anthony J Perkins; Hugh C Hendrie Journal: Med Care Date: 2002-09 Impact factor: 2.983
Authors: Ejovwoke R Ogagarue; Pamela L Lutsey; Ronald Klein; Barbara E Klein; Aaron R Folsom Journal: J Am Heart Assoc Date: 2013-11-19 Impact factor: 5.501
Authors: Wassim Tarraf; Carlos J Rodríguez; Martha L Daviglus; Melissa Lamar; Neil Schneiderman; Linda Gallo; Gregory A Talavera; Robert C Kaplan; Myriam Fornage; Alan Conceicao; Hector M González Journal: J Alzheimers Dis Date: 2017 Impact factor: 4.472
Authors: Hector M González; Wassim Tarraf; Kimystian Harrison; B Gwen Windham; Jonathan Tingle; Alvaro Alonso; Michael Griswold; Gerardo Heiss; David Knopman; Thomas H Mosley Journal: Alzheimers Dement Date: 2017-12-18 Impact factor: 21.566
Authors: Jaime Perales-Puchalt; Michelle L Vidoni; Juan Llibre Rodríguez; Eric D Vidoni; Sandra Billinger; Jeffrey Burns; Maëlenn Guerchet; MinJae Lee Journal: Int J Geriatr Psychiatry Date: 2019-04-23 Impact factor: 3.485
Authors: Melissa Lamar; Ramon A Durazo-Arvizu; Carlos J Rodriguez; Robert C Kaplan; Marisa J Perera; Jianwen Cai; Rebeca A Espinoza Giacinto; Hector M González; Martha L Daviglus Journal: J Int Neuropsychol Soc Date: 2019-09-23 Impact factor: 2.892
Authors: Melissa Lamar; Adeline León; Karina Romo; Ramon A Durazo-Arvizu; Shruti Sachdeva; Richard B Lipton; Krista M Perreira; Linda C Gallo; Jianwen Cai; Tasneem Khambaty; Jessica Carrasco; Maria M Llabre; Lisa T Eyler; Martha L Daviglus; Hector M González Journal: J Alzheimers Dis Date: 2019 Impact factor: 4.472
Authors: Wassim Tarraf; Robert Kaplan; Martha Daviglus; Linda C Gallo; Neil Schneiderman; Frank J Penedo; Krista M Perreira; Melissa Lamar; Albert Chai; Priscilla M Vásquez; Hector M González Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Ronald M Lazar; Virginia J Howard; Walter N Kernan; Hugo J Aparicio; Deborah A Levine; Anthony J Viera; Lori C Jordan; David L Nyenhuis; Katherine L Possin; Farzaneh A Sorond; Carole L White Journal: Stroke Date: 2021-03-15 Impact factor: 7.914
Authors: Mayra L Estrella; Ramon A Durazo-Arvizu; Linda C Gallo; Wassim Tarraf; Carmen R Isasi; Krista M Perreira; Donglin Zeng; Maria J Marquine; Richard B Lipton; Hector M González; Martha L Daviglus; Melissa Lamar Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472